The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for endovascular stroke treatment. Following the release of the main results, the ESCAPE trial investigators convened at a 2-day close-out meeting in March 2015 in Banff, Alberta, Canada. Meeting discussions focused on system implications, procedural characteristics, and future directions. We report the proceedings of the meeting, which provide insights from the trialists into the issues of generalizability, treatment limitations, as well as future directions and opportunities in stroke care optimization.
EmbersonJLeesKRLydenP. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet2014; 384: 1929–1935.
2.
VahediKHofmeijerJJuettlerE. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol2007; 6: 215–222.
3.
JuttlerEUnterbergAWoitzikJ. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med2014; 370: 1091–1100.
4.
LanghornePWilliamsBOGilchristWHowieK. Do stroke units save lives?Lancet1993; 342: 395–398.
5.
BroderickJPPaleschYYDemchukAM. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med2013; 368: 893–903.
6.
CicconeAValvassoriLNichelattiM. Endovascular treatment for acute ischemic stroke. N Engl J Med2013; 368: 904–913.
7.
KidwellCSJahanRGornbeinJ. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med2013; 368: 914–923.
8.
GoyalMDemchukAMMenonBK. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med2015; 372: 1019–1030.
9.
BerkhemerOAFransenPSBeumerD. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med2015; 372: 11–20.
10.
SaverJLGoyalMBonafeA. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med2015; 372: 2285–2295.
11.
JovinTGChamorroACoboE. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med2015; 372: 2296–2306.
12.
CampbellBCMitchellPJKleinigTJ. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med2015; 372: 1009–1018.
13.
DemchukAMGoyalMMenonBK. Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke2015; 10: 429–438.
14.
GoyalMFargenKMMenonBK. Acute stroke, Bayes' theorem and the art and science of emergency decision-making. J Neurointerv Surg2014; 6: 256–259.
15.
MenonBKd'EsterreCDQaziEM. Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology2015; 275: 510–520.
16.
ShinNYKimKEParkM. Dual-phase CT collateral score: a predictor of clinical outcome in patients with acute ischemic stroke. PLoS One2014; 9: e107379.
17.
MenonBKSaverJLGoyalM. Trends in endovascular therapy and clinical outcomes within the nationwide Get With The Guidelines-Stroke registry. Stroke2015; 46: 989–995.
18.
ShethKNSmithEEGrau-SepulvedaMVKleindorferDFonarowGCSchwammLH. Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes. Stroke2015; 46: 732–739.
19.
GoyalMAlmekhlafiMAFanL. Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the interventional management of stroke III trial. Circulation2014; 130: 265–272.
20.
GuptaRHorevANguyenT. Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes. J Neurointerv Surg2013; 5: 294–297.
21.
LigginsJTMlynashMJovinTG. Interhospital variation in reperfusion rates following endovascular treatment for acute ischemic stroke. J Neurointerv Surg2015; 7: 231–233.
22.
KatzanILFurlanAJLloydLE. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA2000; 283: 1151–1158.
23.
RedonJOlsenMHCooperRS. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J2011; 32: 1424–1431.
24.
JohnstonSCMendisSMathersCD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol2009; 8: 345–354.
25.
KrishnamurthiRVFeiginVLForouzanfarMH. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health2013; 1: e259–e281.
ParsonsMSprattNBivardA. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med2012; 366: 1099–1107.
28.
CouttsSBDubucVMandziaJ. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion. Stroke2015; 46: 769–774.
29.
HaleyECJr.ThompsonJLGrottaJC. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke2010; 41: 707–711.
30.
HuangXCheripelliBKLloydSM. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol2015; 14: 368–376.
Okawa M, Tateshima S, Liebeskind D, et al. Successful recanalization for acute ischemic stroke via the transbrachial approach. J Neurointerv Surg 2014, Epub, doi: 10.1136/neurintsurg-2014-011451.
34.
MokinMSnyderKVLevyEIHopkinsLNSiddiquiAH. Direct carotid artery puncture access for endovascular treatment of acute ischemic stroke: technical aspects, advantages, and limitations. J Neurointerv Surg2015; 7: 108–113.
35.
HaddadSHArabiYM. Critical care management of severe traumatic brain injury in adults. Scand J Trauma Resusc Emerg Med2012; 20: 12.
36.
DavisMJMenonBKBaghirzadaLB. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology2012; 116: 396–405.
37.
BrinjikjiWMuradMHRabinsteinAACloftHJLanzinoGKallmesDF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol2015; 36: 525–529.
38.
van den BergLAKoelmanDLBerkhemerOA. Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke. Stroke2015; 46: 1257–1262.
39.
SchonenbergerSMohlenbruchMPfaffJ. Sedation vs. Intubation for Endovascular Stroke TreAtment (SIESTA)—a randomized monocentric trial. Int J Stroke2015; 10: 969–978.
40.
ZinkstokSMRoosYBInvestigatorsA. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet2012; 380: 731–737.
41.
del ZoppoGJHigashidaRTFurlanAJPessinMSRowleyHAGentM. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke1998; 29: 4–11.
42.
AdamsHPJrEffronMBTornerJ. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke2008; 39: 87–99.
43.
ToyodaKKogaMHayakawaMYamagamiH. Acute reperfusion therapy and stroke care in Asia after successful endovascular trials. Stroke2015; 46: 1474–1481.
44.
SutherlandBAMinnerupJBalamiJSArbaFBuchanAMKleinschnitzC. Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke2012; 7: 407–418.
45.
BrataneBTCuiHCookDJBouleyJTymianskiMFisherM. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke2011; 42: 3265–3270.
46.
CookDJTevesLTymianskiM. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature2012; 483: 213–217.
47.
CookDJTevesLTymianskiM. Re-enacting ENACT in gyrencephalic non-human primates: A translational paradigm for the preclinical evaluation of stroke neuroprotectants. Sci Trans Med2012; 4: 154ra133.
48.
HillMDMartinRHMikulisD. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol2012; 11: 942–950.
